The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Antidiabetic Drug Market Outlook 2024

Global Antidiabetic Drug Market Outlook 2024

Publishing Date : Nov, 2021

License Type :
 

Report Code : 1634032

No of Pages : 110

Synopsis
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug

The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.

The global Antidiabetic Drug market was valued at US$ 44610 million in 2020 and is expected to reach US$ 87890 million by the end of 2027, growing at a CAGR of 10.0% during 2021-2027.

This report focuses on Antidiabetic Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antidiabetic Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Antidiabetic Drug Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Alpha-Glucosidase Inhibitors
  • Biguanides, Sulphonylureas
  • Glp-1 Agonist
  • Meglitinides
  • Dpp-4 Inhibitors
  • Sglt–2
  • Thiazolodinediones

Segment by Application

  • Type I Diabetes
  • Type II Diabetes

By Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Sanofi-Aventis
  • Eli Lilly
  • Oramed
  • Takeda
  • Boehringer Ingelheim
  • Novo Nordisk
  • Halozyme Therapeutics
  • Bristol-Myers Squibb
  • Pfizer
  • Tonghua Dongbao
  • Biocon
  • Wockhardt

Scope of the Antidiabetic Drug Market Report

Report Metric

Details

Report Name

Antidiabetic Drug Market

Market size in 2020

US$ 44610 Million

The revenue forecast in 2027

US$ 87890 Million

Growth Rate

CAGR of 10.0% from 2021 to 2027

Market size available for years

2020-2027

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Antidiabetic Drug Market Overview
1.1 Product Overview and Scope of Antidiabetic Drug
1.2 Antidiabetic Drug Segment by Type
1.2.1 Global Antidiabetic Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Alpha-Glucosidase Inhibitors
1.2.3 Biguanides, Sulphonylureas
1.2.4 Glp-1 Agonist
1.2.5 Meglitinides
1.2.6 Dpp-4 Inhibitors
1.2.7 Sglt–2
1.2.8 Thiazolodinediones
1.3 Antidiabetic Drug Segment by Application
1.3.1 Global Antidiabetic Drug Sales Comparison by Application: (2021-2027)
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Global Antidiabetic Drug Market Size Estimates and Forecasts
1.4.1 Global Antidiabetic Drug Revenue 2016-2027
1.4.2 Global Antidiabetic Drug Sales 2016-2027
1.4.3 Antidiabetic Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Antidiabetic Drug Market Competition by Manufacturers
2.1 Global Antidiabetic Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antidiabetic Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antidiabetic Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antidiabetic Drug Manufacturing Sites, Area Served, Product Type
2.5 Antidiabetic Drug Market Competitive Situation and Trends
2.5.1 Antidiabetic Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antidiabetic Drug Players Market Share by Revenue
2.5.3 Global Antidiabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antidiabetic Drug Retrospective Market Scenario by Region
3.1 Global Antidiabetic Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Antidiabetic Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Antidiabetic Drug Market Facts & Figures by Country
3.3.1 North America Antidiabetic Drug Sales by Country
3.3.2 North America Antidiabetic Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antidiabetic Drug Market Facts & Figures by Country
3.4.1 Europe Antidiabetic Drug Sales by Country
3.4.2 Europe Antidiabetic Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antidiabetic Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Antidiabetic Drug Sales by Region
3.5.2 Asia Pacific Antidiabetic Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antidiabetic Drug Market Facts & Figures by Country
3.6.1 Latin America Antidiabetic Drug Sales by Country
3.6.2 Latin America Antidiabetic Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antidiabetic Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Antidiabetic Drug Sales by Country
3.7.2 Middle East and Africa Antidiabetic Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antidiabetic Drug Historic Market Analysis by Type
4.1 Global Antidiabetic Drug Sales Market Share by Type (2016-2021)
4.2 Global Antidiabetic Drug Revenue Market Share by Type (2016-2021)
4.3 Global Antidiabetic Drug Price by Type (2016-2021)

5 Global Antidiabetic Drug Historic Market Analysis by Application
5.1 Global Antidiabetic Drug Sales Market Share by Application (2016-2021)
5.2 Global Antidiabetic Drug Revenue Market Share by Application (2016-2021)
5.3 Global Antidiabetic Drug Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Corporation Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi-Aventis Antidiabetic Drug Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Eli Lilly Antidiabetic Drug Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Oramed
6.3.1 Oramed Corporation Information
6.3.2 Oramed Description and Business Overview
6.3.3 Oramed Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Oramed Antidiabetic Drug Product Portfolio
6.3.5 Oramed Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Corporation Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Takeda Antidiabetic Drug Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Boehringer Ingelheim Antidiabetic Drug Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novo Nordisk Antidiabetic Drug Product Portfolio
6.6.5 Novo Nordisk Recent Developments/Updates
6.7 Halozyme Therapeutics
6.6.1 Halozyme Therapeutics Corporation Information
6.6.2 Halozyme Therapeutics Description and Business Overview
6.6.3 Halozyme Therapeutics Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Halozyme Therapeutics Antidiabetic Drug Product Portfolio
6.7.5 Halozyme Therapeutics Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bristol-Myers Squibb Antidiabetic Drug Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Pfizer Antidiabetic Drug Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Tonghua Dongbao
6.10.1 Tonghua Dongbao Corporation Information
6.10.2 Tonghua Dongbao Description and Business Overview
6.10.3 Tonghua Dongbao Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Tonghua Dongbao Antidiabetic Drug Product Portfolio
6.10.5 Tonghua Dongbao Recent Developments/Updates
6.11 Biocon
6.11.1 Biocon Corporation Information
6.11.2 Biocon Antidiabetic Drug Description and Business Overview
6.11.3 Biocon Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Biocon Antidiabetic Drug Product Portfolio
6.11.5 Biocon Recent Developments/Updates
6.12 Wockhardt
6.12.1 Wockhardt Corporation Information
6.12.2 Wockhardt Antidiabetic Drug Description and Business Overview
6.12.3 Wockhardt Antidiabetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Wockhardt Antidiabetic Drug Product Portfolio
6.12.5 Wockhardt Recent Developments/Updates

7 Antidiabetic Drug Manufacturing Cost Analysis
7.1 Antidiabetic Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antidiabetic Drug
7.4 Antidiabetic Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antidiabetic Drug Distributors List
8.3 Antidiabetic Drug Customers

9 Antidiabetic Drug Market Dynamics
9.1 Antidiabetic Drug Industry Trends
9.2 Antidiabetic Drug Growth Drivers
9.3 Antidiabetic Drug Market Challenges
9.4 Antidiabetic Drug Market Restraints

10 Global Market Forecast
10.1 Antidiabetic Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antidiabetic Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antidiabetic Drug by Type (2022-2027)
10.2 Antidiabetic Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antidiabetic Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antidiabetic Drug by Application (2022-2027)
10.3 Antidiabetic Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antidiabetic Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antidiabetic Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Antidiabetic Drug Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Antidiabetic Drug Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Antidiabetic Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Antidiabetic Drug Covered in This Study
Table 5. Global Antidiabetic Drug Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Antidiabetic Drug Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Antidiabetic Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Antidiabetic Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Antidiabetic Drug Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Antidiabetic Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Antidiabetic Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antidiabetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidiabetic Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antidiabetic Drug Sales by Region (2016-2021) & (K MT)
Table 16. Global Antidiabetic Drug Sales Market Share by Region (2016-2021)
Table 17. Global Antidiabetic Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Antidiabetic Drug Sales by Country (2016-2021) & (K MT)
Table 19. North America Antidiabetic Drug Sales Market Share by Country (2016-2021)
Table 20. North America Antidiabetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Antidiabetic Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Antidiabetic Drug Sales by Country (2016-2021) & (K MT)
Table 23. Europe Antidiabetic Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Antidiabetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Antidiabetic Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Antidiabetic Drug Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Antidiabetic Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Antidiabetic Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Antidiabetic Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Antidiabetic Drug Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Antidiabetic Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Antidiabetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Antidiabetic Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Antidiabetic Drug Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Antidiabetic Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Antidiabetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Antidiabetic Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Antidiabetic Drug Sales (K MT) by Type (2016-2021)
Table 39. Global Antidiabetic Drug Sales Market Share by Type (2016-2021)
Table 40. Global Antidiabetic Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Antidiabetic Drug Revenue Share by Type (2016-2021)
Table 42. Global Antidiabetic Drug Price (USD/MT) by Type (2016-2021)
Table 43. Global Antidiabetic Drug Sales (K MT) by Application (2016-2021)
Table 44. Global Antidiabetic Drug Sales Market Share by Application (2016-2021)
Table 45. Global Antidiabetic Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Antidiabetic Drug Revenue Share by Application (2016-2021)
Table 47. Global Antidiabetic Drug Price (USD/MT) by Application (2016-2021)
Table 48. Sanofi-Aventis Corporation Information
Table 49. Sanofi-Aventis Description and Business Overview
Table 50. Sanofi-Aventis Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Sanofi-Aventis Antidiabetic Drug Product
Table 52. Sanofi-Aventis Recent Developments/Updates
Table 53. Eli Lilly Corporation Information
Table 54. Eli Lilly Description and Business Overview
Table 55. Eli Lilly Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Eli Lilly Antidiabetic Drug Product
Table 57. Eli Lilly Recent Developments/Updates
Table 58. Oramed Corporation Information
Table 59. Oramed Description and Business Overview
Table 60. Oramed Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Oramed Antidiabetic Drug Product
Table 62. Oramed Recent Developments/Updates
Table 63. Takeda Corporation Information
Table 64. Takeda Description and Business Overview
Table 65. Takeda Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Takeda Antidiabetic Drug Product
Table 67. Takeda Recent Developments/Updates
Table 68. Boehringer Ingelheim Corporation Information
Table 69. Boehringer Ingelheim Description and Business Overview
Table 70. Boehringer Ingelheim Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Boehringer Ingelheim Antidiabetic Drug Product
Table 72. Boehringer Ingelheim Recent Developments/Updates
Table 73. Novo Nordisk Corporation Information
Table 74. Novo Nordisk Description and Business Overview
Table 75. Novo Nordisk Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Novo Nordisk Antidiabetic Drug Product
Table 77. Novo Nordisk Recent Developments/Updates
Table 78. Halozyme Therapeutics Corporation Information
Table 79. Halozyme Therapeutics Description and Business Overview
Table 80. Halozyme Therapeutics Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Halozyme Therapeutics Antidiabetic Drug Product
Table 82. Halozyme Therapeutics Recent Developments/Updates
Table 83. Bristol-Myers Squibb Corporation Information
Table 84. Bristol-Myers Squibb Description and Business Overview
Table 85. Bristol-Myers Squibb Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Bristol-Myers Squibb Antidiabetic Drug Product
Table 87. Bristol-Myers Squibb Recent Developments/Updates
Table 88. Pfizer Corporation Information
Table 89. Pfizer Description and Business Overview
Table 90. Pfizer Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Pfizer Antidiabetic Drug Product
Table 92. Pfizer Recent Developments/Updates
Table 93. Tonghua Dongbao Corporation Information
Table 94. Tonghua Dongbao Description and Business Overview
Table 95. Tonghua Dongbao Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Tonghua Dongbao Antidiabetic Drug Product
Table 97. Tonghua Dongbao Recent Developments/Updates
Table 98. Biocon Corporation Information
Table 99. Biocon Description and Business Overview
Table 100. Biocon Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Biocon Antidiabetic Drug Product
Table 102. Biocon Recent Developments/Updates
Table 103. Wockhardt Corporation Information
Table 104. Wockhardt Description and Business Overview
Table 105. Wockhardt Antidiabetic Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Wockhardt Antidiabetic Drug Product
Table 107. Wockhardt Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Antidiabetic Drug Distributors List
Table 111. Antidiabetic Drug Customers List
Table 112. Antidiabetic Drug Market Trends
Table 113. Antidiabetic Drug Growth Drivers
Table 114. Antidiabetic Drug Market Challenges
Table 115. Antidiabetic Drug Market Restraints
Table 116. Global Antidiabetic Drug Sales Forecast by Type (2022-2027) & (K MT)
Table 117. Global Antidiabetic Drug Sales Market Share Forecast by Type (2022-2027)
Table 118. Global Antidiabetic Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 119. Global Antidiabetic Drug Revenue Market Share Forecast by Type (2022-2027)
Table 120. Global Antidiabetic Drug Sales Forecast by Application (2022-2027) & (K MT)
Table 121. Global Antidiabetic Drug Sales Market Share Forecast by Application (2022-2027)
Table 122. Global Antidiabetic Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 123. Global Antidiabetic Drug Revenue Market Share Forecast by Application (2022-2027)
Table 124. Global Antidiabetic Drug Sales Forecast by Region (2022-2027) & (K MT)
Table 125. Global Antidiabetic Drug Sales Market Share Forecast by Region (2022-2027)
Table 126. Global Antidiabetic Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 127. Global Antidiabetic Drug Revenue Market Share Forecast by Region (2022-2027)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antidiabetic Drug
Figure 2. Global Antidiabetic Drug Market Share by Type in 2020 & 2027
Figure 3. Alpha-Glucosidase Inhibitors Product Picture
Figure 4. Biguanides, Sulphonylureas Product Picture
Figure 5. Glp-1 Agonist Product Picture
Figure 6. Meglitinides Product Picture
Figure 7. Dpp-4 Inhibitors Product Picture
Figure 8. Sglt–2 Product Picture
Figure 9. Thiazolodinediones Product Picture
Figure 10. Global Antidiabetic Drug Market Share by Application in 2020 & 2027
Figure 11. Type I Diabetes
Figure 12. Type II Diabetes
Figure 13. Global Antidiabetic Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Antidiabetic Drug Market Size 2016-2027 (US$ Million)
Figure 15. Global Antidiabetic Drug Sales 2016-2027 (K MT)
Figure 16. Global Antidiabetic Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Antidiabetic Drug Sales Share by Manufacturers in 2020
Figure 18. Global Antidiabetic Drug Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Antidiabetic Drug Players: Market Share by Revenue in 2020
Figure 20. Antidiabetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Antidiabetic Drug Sales Market Share by Region (2016-2021)
Figure 22. Global Antidiabetic Drug Sales Market Share by Region in 2020
Figure 23. Global Antidiabetic Drug Revenue Market Share by Region (2016-2021)
Figure 24. Global Antidiabetic Drug Revenue Market Share by Region in 2020
Figure 25. U.S. Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Antidiabetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Antidiabetic Drug by Type (2016-2021)
Figure 50. Sales Market Share of Antidiabetic Drug by Application (2016-2021)
Figure 51. Sales Market Share of Antidiabetic Drug by Application in 2020
Figure 52. Revenue Share of Antidiabetic Drug by Application (2016-2021)
Figure 53. Revenue Share of Antidiabetic Drug by Application in 2020
Figure 54. Manufacturing Cost Structure of Antidiabetic Drug
Figure 55. Manufacturing Process Analysis of Antidiabetic Drug
Figure 56. Antidiabetic Drug Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’